Hypertensive Emergency Management

First-Line Medication Selection

The American Heart Association recommends labetalol as the preferred initial treatment over Lasix in most hypertensive emergencies due to its rapid onset, predictable dose-response relationship, and specific indications in conditions like aortic dissection, eclampsia, and acute coronary syndromes 1, 2
Labetalol is indicated for acute aortic dissection, requiring rapid lowering of SBP to ≤120 mmHg; beta blockade should precede vasodilator administration 1
Labetalol is considered safe and effective for eclampsia or preeclampsia 2, 3
Labetalol reduces afterload without increasing heart rate in acute coronary syndromes 2
Labetalol is the first-line treatment for acute ischemic and hemorrhagic stroke when BP reduction is indicated 3

Labetalol has an onset of action of 5-10 minutes 2
Labetalol has a duration of 3-6 hours 2
The recommended dosing for labetalol is 0.25-0.5 mg/kg IV bolus; 2-4 mg/min continuous infusion until goal BP is reached, thereafter 5-20 mg/h 2

The general goal is to reduce mean arterial pressure by 20-25% over several hours 4
Excessive BP reduction (>50% decrease in MAP) has been associated with ischemic stroke and death 4
The target BP is 160/100 mmHg within 2-6 hours, then normalize over 24-48 hours 4, 5

Continuous BP monitoring in an intensive care setting is recommended 4
Patients are often volume depleted due to pressure natriuresis; IV saline may be needed to prevent precipitous BP falls 4
Contraindications to labetalol include second or third-degree heart block, bradycardia, reactive airways disease, and systolic heart failure 1, 2

The American College of Cardiology recommends labetalol for acute aortic dissection, requiring rapid lowering of SBP to ≤120 mmHg within 20 minutes 6
The American College of Cardiology recommends labetalol as first-line therapy for eclampsia/preeclampsia, with target SBP <160 mmHg and DBP <105 mmHg 6
Labetalol is recommended for acute coronary syndromes, as it reduces afterload without increasing heart rate, decreasing myocardial oxygen demand 6
The American College of Cardiology suggests labetalol for catecholamine excess states, particularly in pheochromocytoma, cocaine toxicity, and clonidine withdrawal 6
Metoprolol is primarily indicated for acute coronary syndrome and acute pulmonary edema in specific contexts, but is not listed as a preferred agent for most hypertensive emergencies 6
The 2017 ACC/AHA guidelines do not prominently feature metoprolol as a first-line agent for hypertensive emergencies 6

The American College of Cardiology lists absolute contraindications for labetalol, including second- or third-degree heart block, severe bradycardia (<60 bpm), decompensated heart failure, and active asthma or severe bronchospasm 6
The American College of Cardiology lists relative contraindications for labetalol, including reactive airways disease and COPD 6
Metoprolol is contraindicated in reactive airways disease, chronic obstructive pulmonary disease, second- or third-degree heart block, and bradycardia 6
Metoprolol may worsen heart failure and should not be given in decompensated HF 6

Intravenous labetalol should be avoided in patients presenting with acute decompensated heart failure (ADHF) and a hypertensive emergency because beta‑blockade can further depress myocardial contractility and precipitate worsening failure; instead, intravenous vasodilators are recommended as first‑line therapy. European Society of Cardiology (ESC) 2005 guidelines. 7
The ESC 2005 guidelines explicitly state that β‑blockers must not be used when pulmonary oedema accompanies a hypertensive crisis. 7

Intravenous nitroglycerin or nitroprusside are the preferred agents for rapidly decreasing venous preload and arterial afterload while enhancing coronary blood flow in ADHF with hypertensive emergency. ESC 2005. 7
When clear volume overload is present in a patient with a long history of chronic heart failure, add intravenous loop diuretics to the vasodilator regimen. ESC 2005. 7
Calcium‑channel blockers such as nicardipine may be considered as adjuncts because most of these patients have diastolic dysfunction with increased after‑load. ESC 2005. 7

Aim for an initial rapid reduction of systolic or diastolic blood pressure by approximately 30 mm Hg within the first few minutes, followed by a more gradual decline over several hours. ESC 2005. 7
Do not attempt to normalize blood pressure to typical values; excessive reduction can impair organ perfusion and worsen outcomes. ESC 2005. 7
The target blood pressure should be the level measured before the hypertensive crisis began. ESC 2005. 7
Avoid lowering blood pressure below the pre‑crisis baseline, as this may further compromise organ perfusion. ESC 2005. 7

Provide supplemental oxygen, continuous positive airway pressure (CPAP), or other forms of non‑invasive ventilation as needed to manage pulmonary congestion. ESC 2005. 7
If respiratory failure persists, brief invasive mechanical ventilation may be employed. ESC 2005. 7

In the rare scenario of pheochromocytoma‑induced hypertensive crisis with ADHF, labetalol can be used cautiously: administer slow intravenous boluses of 10 mg with close heart‑rate and blood‑pressure monitoring, followed by an infusion of 50–200 mg/h. ESC 2005. 7

Beta‑blockers may be safely continued in patients with stable, compensated heart failure, but they should be discontinued during acute decompensation with pulmonary oedema. European Journal of Heart Failure 2015. 8

Never select labetalol as the first‑line agent for ADHF with hypertensive emergency; this contradicts ESC guideline recommendations. 7
Do not confuse hypertensive urgency (no pulmonary oedema) with hypertensive emergency; labetalol may be acceptable in urgency but not when ADHF is present. (supported by guideline context). 7